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http:WHAT THIS PAPER ADDS
Smoking cessation is a fundamental part of taking care of patients with abdominal aortic aneurysm (AAA), yet
little is known about how to support this group of patients. This base-line study of 65-year-old smokers
attending AAA screening helps us to understand the modest effect of standard healthcare counselling. There was
a reduction of smoking in all groups; however, those with AAA reduced their smoking more than those with a
normal or sub-aneurysmal (25e29 mm) aorta. They also recalled more often having been counselled to stop
smoking. Further research is needed to identify a more effective support.Objectives: To study smoking habits among men with abdominal aortic aneurysm at screening at 65 years of age,
and during follow-up, as a base-line study to evaluate future interventions.
Design: Nested caseecontrol study.
Patients and methods: Between 2006 and 2011, 8150 65-year-old men (compliance 85%) were screened for AAA
in Uppsala County, Sweden. Among 292 men with an aortic diameter of at least 25 mm, 77 were active smokers
at the time of screening. At follow-up of smoking habits in 2012, 53 men (69%) participated in this study, 28 had
an AAA of at least 30 mm and 25 a sub-aneurysmal aorta (SAA) 25e29 mm at baseline. For each case, one
control was randomly selected, all active smokers with aortic diameter less than 25 mm at baseline, matched for
age and year of screening. Telephone interviews were performed at a median 34 months (range: 4e67) after
screening.
Results: Men with AAA had hypertension more often than controls (68% vs. 23%, p < .001). Men with AAA and
SAA reported more smoking years than controls (p ¼ .017). Cessation rate among patients with AAA did not
differ signiﬁcantly compared with men with an aorta less than 30 mm (29% vs. 15%, p ¼ .159), but they had
reduced their consumption of cigarettes/day signiﬁcantly more than men with SAA and controls (8.2 vs. 3.0
vs. 4.5, p ¼ .030). Men with AAA recalled having been informed about the importance of smoking cessation at
the time of screening more often (p ¼ .031). There was no difference in growth of the AAA between those who
continued, and those who quit smoking (2.03 vs. 2.01 mm/year, p ¼ .982), but the study was not powered to
study AAA growth.
Conclusions: Although counselling in a normal healthcare setting had some effect, the results indicate a need to
tailor interventions to further increase smoking cessation rates among men diagnosed with both AAA and SAA.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The most severe complication of abdominal aortic aneu-
rysm (AAA) is rupture with high mortality rate, even after
surgical repair. Patients with AAA are often asymptomatic
but the disease can be detected by screening persons at risk
with ultrasound imaging.1e5 After 13 years of follow-up
after screening, all-cause-mortality was reduced with 3%responding author. M. Björck, Department of Surgical Sciences,
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//dx.doi.org/10.1016/j.ejvs.2014.04.010in the entire population of elderly men invited to screening
in the UK.6 Interestingly, the reduction of mortality was not
conﬁned to aneurysm-related deaths. For instance, in the
10-year results of the MASS trial the screened population
had a reduction of 141 aneurysm-related deaths, but also a
reduction of 124 deaths related to ischaemic heart disease.7
Although not speciﬁcally reported, the authors hypothesize
that this reduction of non-aneurysm-related mortality may
be related to smoking cessation and secondary prevention
among the patients with detected AAA.
Swedish AAA screening has shown that the prevalence of
the disease was lower than expected, suggesting that there
is a change in epidemiology probably related to changes in
Figure 1. Study design.
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the UK.9 Thirteen per cent of the general 65-year-old male
population screened for AAA in the Swedish study reported
current smoking at screening and 63% had ever smoked.8
Among those having AAA, however, 33% were active
smokers and 87% had ever smoked. There is a substantially
stronger association between ever smoking and AAA than
the association between ever smoking and coronary or
cerebrovascular disease.10 The number of smoking years
and pack-years among past and current smokers are
correlated with the development and progression of aortic
aneurysms.2 A correlation between smoking cessation and
decreased growth rate of the aneurysms among patients
under surveillance also has been shown.2,11 Smoking
cessation for AAA patients is cost-effective, because of
increased long-term survival, as well as a decreased need
for surgery.12 Despite this great importance of smoking, and
of smoking cessation, among patients with AAA, no data
were found on how normal healthcare affects long-term
smoking habits in this patient group.
Although the most common deﬁnition of AAA in men is
an aortic diameter of at least 30 mm,13 there is accumu-
lating evidence that men with an aortic diameter in the
range 25e29 mm at the age of 65, very often develop AAA
later in life1416 and have an increased risk of cardiovascular
events in general. This group, which is approximately the
same size as those with an AAA,8,16 is often referred to as
having a “sub-aneurysmal aorta” or an “aneurysm in for-
mation”. In this investigation the term sub-aneurysmal
aorta (SAA) was chosen.
The aim of this study was to assess smoking habits in a
contemporary cohort of 65-year-old men invited for AAA
screening, and the importance of the screening result on
smoking cessation over a 5-year follow-up period. The
purpose of such a descriptive study was to form a basis for
further research aimed at developing a tailored interventionprogramme to help 65-year-old men with a dilated aorta to
stop smoking.
PATIENTS AND METHODS
A total of 8150 men were screened for AAA in the County of
Uppsala, Sweden between September 2006 and December
2011. Two hundred and ninety-two men were diagnosed
with an aorta of at least 25 mm, among whom 77 were
active smokers at the time of screening. Eighteen smokers
did not participate in the continued research programme
for the following reasons: two died, 11 declined active
participation in the research, three did not respond, and
two did not speak Swedish. At follow-up, four men could
not be reached and two declined participation in this
particular study (Fig. 1).
Among the 53 men (69% of the original cohort of 77
smoking men with a screening detected aorta 25 mm)
constituting the study population of this investigation, 28
had an AAA of at least 30 mm and 25 had a SAA of 25e
29 mm. For each case (n ¼ 53), one control, a smoker at the
time of screening with a normal aortic diameter, matched
for age and time of screening, was randomly recruited to
participate in the study (Fig. 1). Selection of controls took
place with a lottery system based on personal identity code.
In all, 68 potential controls were invited, 13 did not answer,
one declined actively, and one claimed he had not been a
smoker at baseline. Follow-up interviews for cases and
controls were performed at a median of 34 months (range
4e67 months) after baseline screening.
The regional ethical review board in Uppsala approved
the study.Routines regarding smoking cessation
The patients with both AAA and SAA were informed by
telephone or at a follow up visit, by the doctor or a
Table 1. Baseline characteristics and follow-up.
AAA
30 mm
SAA
25e29 mm
Aorta
<25 mm
p
n ¼ 28 n ¼ 25 n ¼ 53
Age at screening 65 65 65 n/a
Follow-up (months), median (range) 30 (4e67) 30 (11e67) 29 (5e67)
Mean (SD) 30.4 (21) 37.6 (20) 33.2 (20) .43
Coronary disease 4 (14%) 8 (32%) 8 (15%) .158
Hypertension 19 (68%) 8 (32%) 12 (23%) <.001
Diabetes 4 (14%) 1 (4%) 2 (4%) .168
Asthma/COPD 1 (4%) 0 (0%) 4 (8%) .313
Smoking years, median (range) 46 (30e51) 50 (42e55) 45 (20e55)
Mean (SD) 45.2 (6.0) 48.4 (3.0) 43.7 (7.9) .017
Cigarettes per day, median (range) 20 (4e30) 15 (3e40) 15 (1e30)
Mean (SD) 17.6 (5.9) 15.0 (7.6) 15.8 (6.0) .336
Pack years, median (range) 45 (9.8e75) 34 (7.5e104) 35 (1.5e82.5)
Mean (SD) 39.9 (15.3) 36.5 (19.2) 35.1 (15.4) .451
AAA ¼ Abdominal aortic aneurysm; SAA ¼ Sub-aneurysmal aorta; COPD ¼ Chronic obstructive pulmonary disease.Follow-up is the time
from AAA screening until the interview.
140 S. Bohlin et al.specialized nurse, that smoking cessation can reduce the
growth of the AAA, and prolong life. They were also offered
nicotine replacement therapy. This information was
repeated on follow-up visits, meaning that the information
was given more times to those with larger AAAs. Persons
with SAA were examined by ultrasound after 5 years, those
with AAA between 30 and 39 mm after 2 years, and then
more frequently depending on the size of the AAA.
The controls, smokers who had a normal aorta on AAA
screening, were not given any information on the impor-
tance of smoking cessation.Figure 2. Mean (95% CI) differences in cig/day from baseline to
follow-up.Procedure
Data on the smoking habits of the cases and controls and
co-morbidities (coronary disease, diabetes, chronic
obstructive pulmonary disease [COPD], and hypertension)
at baseline (time of ﬁrst screening, at age 65) were based
on a questionnaire used throughout Sweden.
Data on smoking habits during follow-up (smoking/non-
smoking, number of cigarettes/day, number of smoking
years, reasons for continuing/quitting smoking) for all cases
and controls were retrieved by a structured telephone
interview between March and May 2012. All the interviews
were performed by the ﬁrst author (SB) who was not
blinded to the diameter of the aorta of the person inter-
viewed. Smoking refers to smoking cigarettes, cigars, and/or
pipe. One gram of smoked tobacco other than cigarettes is
considered equivalent to one cigarette.17 Although depth of
inhalation varies between smokers,18,19 and on different
types of tobacco smoked, pipe and cigar smokers have a
higher risk of developing cardiovascular and cerebrovascular
diseases compared with non-smokers.20,21 Pack-years were
calculated as (cigarettes/day  smoking years)/20.22
Smoking cessation was deﬁned as continuous non-
smoking for at least 3 months at follow-up.
Aortic growth rate data were available for 25 (89%) men
with AAA and seven (28%) men with SA in February 2014.Men with small aneurysms and/or with screening dates
2009e2011 had not been followed up at that time.Statistics
Statistical analysis was performed with SPSS PC version 20.0
(SPSS, Chicago, IL, USA). Differences in proportions were
analysed with uncorrected chi-square test and results pre-
sented with 95% conﬁdence intervals. Continuous data
were compared with ANOVA-tests. Signiﬁcance was
assumed when p values were less than .05.RESULTS
Baseline characteristics for cases and controls are presented
in Table 1. Persons with an aortic diameter of at least
25 mm had hypertension more often and more smoking
years, than those with an aortic diameter less than 25 mm.
At follow-up, eight men with AAA (29%), three men with
SAA (12%) and nine men with normal aortas (17%) had quit
smoking (p ¼ .27). The cessation rates among patients with
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compared with all men with an aorta less than 30 mm (29%
vs. 15%, p ¼ .159). Men with an AAA had reduced their
consumption of cigarettes/day signiﬁcantly more than men
with SAA and men with normal aorta at follow-up (8.2 [SD
8.7] vs. 3.0 [4.9] vs. 4.5 [7.5], p ¼ .030, Fig. 2).
Among current smokers at follow-up, eight patients
(40%) with AAA, eight men (36%) with SAA and seven of the
controls (16%) reported attempts to quit smoking. Whereas
21/28 (75%) men with AAA recalled having been informed
about the importance of smoking cessation at the time of
screening, the corresponding proportion for men with SAA
was 10/25 (40%, p ¼ .031).
Reasons for continuing smoking, reported by men in all
three groups (n ¼ 86), were the following: smoking is a
habit, or a bad habit, that is hard to change (n ¼ 22), a
desire to continue smoking because of a good taste
(n ¼ 21), smoking has a calming effect (n ¼ 15), fear of
physical reactions such as weight gain (n ¼ 9), or for no
particular reason (n ¼ 9). Five patients reported not being
able to quit and two were currently trying to quit. Three had
other explanations.
Four of eight patients with an AAA and one of three men
with a SAA, who successfully quitted smoking, reported that
being diagnosed with AAA was the main reason for their
decision to quit smoking. The subject with a SAA had just
been diagnosed with an AAA at 5-year follow-up after
baseline, thus actually belonging to the AAA group at the
time of smoking cessation.
There was no difference in growth of the AAAs between
those who continued, and those who quit smoking (2.03 vs.
2.01 mm/year, p ¼ .982).DISCUSSION
This investigation only focused on those who were active
smokers at the time of screening for AAA, at the age of 65.
As smoking is the dominant risk factor associated with AAA;
it raises the risk for AAA about threefold.8 In addition, men
with SAA have an increased risk of developing AAA16 and
this risk, combined with the elevated risk caused by
smoking for developing AAA, emphasizes the importance of
thorough studies of these men’s smoking habits.
There is a trend towards patients diagnosed with AAA
being more prone to smoking cessation than men with a
SAA, or controls. A higher proportion of patients with AAA
compared with those with SAA and controls (75% vs. 45%)
recalled having been informed about the importance of
smoking cessation at the time of screening. The study was
performed as a base-line study characterizing the result of
normal healthcare, in a Swedish contemporary context. It is
natural that a patient diagnosed with AAA both receives
more speciﬁc information about the importance of smoking
cessation, and also may be more sensitive to that infor-
mation, if it is given in an adequate way. The patients with
AAA had more frequent follow-up, depending on the size of
the AAA, resulting in the information on smoking cessation
being repeated. The subjects with SAA at 65 years of agewere given the information that they had a normal aorta,
but that it was a border-line measurement and therefore
they would be invited for a rescreening at the age of 70.
According to the Swedish National Institute of Public
Health, among Swedes in 2004e2011, the highest rates of
smoking are among men aged 45e64 years, whereas there
is a marked and progressive reduction of smoking rates in
ages 65e84 years.23 Possible explanations for this decrease
in smoking rates with higher age are the ﬁnancial situation
of retired men, and age-related symptoms. Thus, there
seems to be a natural course of decreasing smoking rates
with increasing age. This trend was observed in all three
groups in this investigation, although the quit-rate tended
to be higher among patients with AAA. These trends of
decreasing smoking rates over time, and with increasing
age, result in a risk of exaggerating the efﬁcacy of smoking
cessation programmes, and underline the importance of
having a true age-adjusted comparator.
The present results indicate that whereas men with
abdominal aortic dilatation 25e30 mm continue their risk
behaviour with regard to smoking with the same frequency
as the general population, patients with AAA tend to
improve their smoking habits. Information on smoking
habits at baseline was collected at the time of AAA
screening, registered in the local database, and later
conﬁrmed by the patients during the telephone interviews
in 2012. There is a possibility that smokers do not recall
correctly, underestimate or overestimate smoking habits if a
few years have passed. Counting pack-years retrospectively
seems to be quite reliable, however, and has been validated
in previous research.22 Pack-years were only counted at
baseline (at the age of 65) in this study as additional
smoking years in 2012 were not of interest in this study. No
blood samples of biochemical markers were taken to
conﬁrm smoking cessation or to estimate the reported
number of cigarettes smoked, which is a limitation of this
study.
It is a difﬁcult task to help patients quit smoking. A
Cochrane review shows that simple advice from doctors to
patients has a small effect on cessation rates.24 These
ﬁndings suggest that patients diagnosed with AAA may
beneﬁt from receiving more focused information on the
consequences of continued smoking on the development of
the AAA, and the beneﬁts of smoking cessation. The exact
mechanisms underlying the decisions of men with AAA to
continue or quit smoking need to be further explored, and
such investigations are in progress.
The importance of taking advantage of patients with a
newly diagnosed AAA being more sensitive to information
on the health beneﬁts of smoking cessation is highlighted
by the fact that approximately one-third of the survival
beneﬁt associated with AAA screening in the MASS study6
was explained by reasons other than a decrease of aortic
rupture. It is reasonable to assume that this effect was
associated with secondary preventive measures, including
counselling on smoking cessation.
An interesting possibility would be to offer smoking
cessation aid to smokers with a normal aorta on screening.
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but may also have a great potential public health beneﬁt.
This issue needs to be addressed in future investigations.
A limitation of the study is the small number of subjects,
which could explain the lack of signiﬁcant differences when
comparing smoking habits of men with AAA and men with
SAA or controls. On the other hand, to the authors’
knowledge there is no previous investigation about the
smoking patterns in this speciﬁc patient group, before and
after screening for AAA. One strength of the study is that it is
population-based, and that compliance was as high as 84%,
when 65-year-old men were invited to screening for AAA.8
In conclusion, smoking cessation rates among men with
abdominal aortic aneurysm may be higher compared with
controls and it is possible that counselling about smoking
cessation plays an important role.Whether a tailored smoking
cessation programme for patients with AAA could increase
the cessation rate further, and whether repeated advice is
more effective than informing once, are questions that
remain to be answered. People with a sub-aneurysmal aorta
could probably also beneﬁt from the same speciﬁc smoking
cessation intervention, and further research to elucidate how
this group should be counselled is warranted. As screening of
older men for AAA is becoming clinical practice in many
countries,25e27 this information is warranted to be able to
maximize the public health beneﬁt of such programmes.
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